Dose recommendations for anticancer drugs in patients with renal or hepatic impairment.
Krens SD, Lassche G, Jansman FGA, Desar IME, Lankheet NAG, Burger DM, van Herpen CML, van Erp NP.
Lancet Oncol. 2019 Apr;20(4):e200-e207. doi: 10.1016/S1470-2045(19)30145-7.
Narrative review of migraine management in patients with renal or hepatic disease.
Stern JI, Datta S, Chiang CC, Garza I, Vieira DL, Robertson CE.
Headache. 2023 Jan;63(1):9-24. doi: 10.1111/head.14437.
Dose recommendations for anticancer drugs in patients with renal or hepatic impairment: an update.
Giraud EL, de Lijster B, Krens SD, Desar IME, Boerrigter E, van Erp NP.
Lancet Oncol. 2023 Jun;24(6):e229. doi: 10.1016/S1470-2045(23)00216-4.
Acute Kidney Injury and CKD Associated with Hematopoietic Stem Cell Transplantation.
Renaghan AD, Jaimes EA, Malyszko J, Perazella MA, Sprangers B, Rosner MH.
Clin J Am Soc Nephrol. 2020 Feb 7;15(2):289-297. doi: 10.2215/CJN.08580719. Epub 2019 Dec 13.
Bioartificial organ support for hepatic, renal, and hematologic failure.
Maguire PJ, Stevens C, Humes HD, Shander A, Halpern NA, Pastores SM.
Crit Care Clin. 2000 Oct;16(4):681-94. doi: 10.1016/s0749-0704(05)70140-8.
Impact of hepatic impairment and renal failure on the pharmacokinetics of linezolid and its metabolites: contribution of hepatic metabolism and renal excretion.
Liu J, Pang Y, Li W, Sun J, He Y, Guo Y, Dong J.
Antimicrob Agents Chemother. 2025 May 7;69(5):e0189224. doi: 10.1128/aac.01892-24. Epub 2025 Apr 14.
Clinical outcomes of MAFLD versus NAFLD: A meta-analysis of observational studies.
Pennisi G, Infantino G, Celsa C, Di Maria G, Enea M, Vaccaro M, Cannella R, Ciccioli C, La Mantia C, Mantovani A, Mercurio F, Tilg H, Targher G, Di Marco V, Cammà C, Petta S.
Liver Int. 2024 Nov;44(11):2939-2949. doi: 10.1111/liv.16075. Epub 2024 Aug 19.
Effect of experimentally induced hepatic and renal failure on the pharmacokinetics of topiramate in rats.
Matar KM, Tayem YI.
Biomed Res Int. 2014;2014:570910. doi: 10.1155/2014/570910. Epub 2014 Jun 9.
Current concepts in pain management: pharmacologic options for the pediatric, geriatric, hepatic and renal failure patient.
Stern SS, Ponticello MN.
Clin Podiatr Med Surg. 2008 Jul;25(3):381-407; vi. doi: 10.1016/j.cpm.2008.02.013.
Renal failure and dialysis therapy in children with hepatic failure in the perioperative period of orthotopic liver transplantation.
Ellis D, Avner ED.
Clin Nephrol. 1986 Jun;25(6):295-303.
